Workflow
Sell ABT Stock Ahead Of Its Q2 Earnings?
AbbottAbbott(US:ABT) Forbes·2025-07-15 11:35

Core Insights - Abbott Laboratories (NYSE: ABT) is set to announce its second-quarter earnings on July 17, 2025, with historical stock reactions to earnings announcements indicating potential trading strategies [2][3]. Earnings Expectations - Analysts project Abbott's second-quarter earnings to be $1.25 per share on revenues of $11.02 billion, a significant increase from the previous year's earnings of $1.14 per share on sales of $10.38 billion [3]. Historical Stock Performance - Over the past five years, Abbott's stock has experienced negative one-day returns following earnings releases in 60% of cases, with a median negative return of -2.4% and a peak negative return of -6.5% [3][6]. - In the last three years, the percentage of positive one-day returns increased to 50%, with a median positive return of 3.0% for the eight positive returns recorded [6]. Market Position and Financials - Abbott Laboratories has a market capitalization of approximately $230 billion and generated $42 billion in revenue over the last year, with an operating income of $7.1 billion and a net income of $14 billion [4]. Trading Strategies - Traders may consider pre-earnings positioning based on historical probabilities or wait for earnings results to inform their trading decisions [5]. - A strategy involving the correlation between short-term (1D) and medium-term (5D) returns post-earnings can be employed, particularly if a strong correlation is identified [7].